Effect of beta-enantiomeric and racemic nucleoside analogues on mitochondrial functions in HepG2 cells. Implications for predicting drug hepatotoxicity.

[1]  J. Ojwang,et al.  Inhibition of episomal hepatitis B virus DNA in vitro by 2,4-diamino-7- (2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-pyrrolo[2,3-d]pyrimidine , 1995, Antimicrobial agents and chemotherapy.

[2]  M. Swartz.  Mitochondrial toxicity--new adverse drug effects. , 1995, The New England journal of medicine.

[3]  J. Ojwang,et al.  Synthesis and anti-DNA viral activities in vitro of certain 2,4-disubstituted-7-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)pyrrolo[2,3-d d pyrimidine nucleosides. , 1995, Journal of medicinal chemistry.

[4]  V. Nair,et al.  Antiviral activities of isometric dideoxynucleosides of D- and L-related stereochemistry , 1995, Antimicrobial agents and chemotherapy.

[5]  R. Schinazi,et al.  Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells. , 1995, The Journal of clinical investigation.

[6]  C. Tsai,et al.  Effect of anti-HIV 2'-beta-fluoro-2',3'-dideoxynucleoside analogs on the cellular content of mitochondrial DNA and on lactate production. , 1994, Biochemical pharmacology.

[7]  J. Colacino,et al.  Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in culture , 1994, Antimicrobial Agents and Chemotherapy.

[8]  R. Schinazi,et al.  Pure nucleoside enantiomers of beta-2',3'-dideoxycytidine analogs are selective inhibitors of hepatitis B virus in vitro , 1994, Antimicrobial Agents and Chemotherapy.

[9]  R. Schinazi,et al.  Anti-human immunodeficiency virus activities of the beta-L enantiomer of 2',3'-dideoxycytidine and its 5-fluoro derivative in vitro , 1994, Antimicrobial Agents and Chemotherapy.

[10]  J. Sommadossi,et al.  Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis , 1994, Antimicrobial Agents and Chemotherapy.

[11]  G. Dutschman,et al.  Antiviral activity of 2′,3′-dideoxy-β-L-5-fluorocytidine (β-L-FddC) and 2′,3′-dideoxy-β-L-cytidine (β-L-ddC) against hepatitis B virus and human immunodeficiency virus type 1 in vitro , 1994 .

[12]  V. Skalski,et al.  The biochemical basis for the differential anti-human immunodeficiency virus activity of two cis enantiomers of 2',3'-dideoxy-3'-thiacytidine. , 1993, The Journal of biological chemistry.

[13]  R. Schinazi,et al.  Structure-activity relationships of beta-D-(2S,5R)- and alpha-D-(2S,5S)-1,3-oxathiolanyl nucleosides as potential anti-HIV agents. , 1993, Journal of medicinal chemistry.

[14]  J. Sommadossi.  Nucleoside analogs: similarities and differences. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  R. Schinazi,et al.  Asymmetric synthesis and biological evaluation of beta-L-(2R,5S)- and alpha-L-(2R,5R)-1,3-oxathiolane-pyrimidine and -purine nucleosides as potential anti-HIV agents. , 1993, Journal of medicinal chemistry.

[16]  R. Schinazi,et al.  1,3-dioxolanylpurine nucleosides (2R,4R) and (2R,4S) with selective anti-HIV-1 activity in human lymphocytes. , 1993, Journal of medicinal chemistry.

[17]  L W Frick,et al.  The anti-hepatitis B virus activities, cytotoxicities, and anabolic profiles of the (-) and (+) enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine , 1992, Antimicrobial Agents and Chemotherapy.

[18]  R. Schinazi,et al.  Comparison of cytotoxicity of the (-)- and (+)-enantiomer of 2',3'-dideoxy-3'-thiacytidine in normal human bone marrow progenitor cells. , 1992, Biochemical pharmacology.

[19]  R F Schinazi,et al.  Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine , 1992, Antimicrobial Agents and Chemotherapy.

[20]  G. Maga,et al.  L-thymidine is phosphorylated by herpes simplex virus type 1 thymidine kinase and inhibits viral growth. , 1992, Journal of medicinal chemistry.

[21]  R. Schinazi,et al.  Deoxycytidine deaminase-resistant stereoisomer is the active form of (+/-)-2',3'-dideoxy-3'-thiacytidine in the inhibition of hepatitis B virus replication. , 1992, The Journal of biological chemistry.

[22]  William,et al.  Zidovudine induces molecular, biochemical, and ultrastructural changes in rat skeletal muscle mitochondria. , 1992, The Journal of clinical investigation.

[23]  R. Schinazi,et al.  Synthesis of enantiomerically pure (2'R,5'S)-(-)-1-(2-hydroxymethyloxathiolan-5-yl)cytosine as a potent antiviral agent against hepatitis B virus (HBV) and human immunodeficiency virus (HIV) , 1992 .

[24]  R. Schinazi,et al.  Activities of the four optical isomers of 2',3'-dideoxy-3'-thiacytidine (BCH-189) against human immunodeficiency virus type 1 in human lymphocytes , 1992, Antimicrobial Agents and Chemotherapy.

[25]  C. H. Chen,et al.  The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2',3'-dideoxycytidine. , 1992, The Journal of biological chemistry.

[26]  R. Schinazi,et al.  Inhibition of the replication of hepatitis B virus in vitro by 2',3'-dideoxy-3'-thiacytidine and related analogues. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[27]  C. H. Chen,et al.  Effect of anti-human immunodeficiency virus nucleoside analogs on mitochondrial DNA and its implication for delayed toxicity. , 1991, Molecular pharmacology.

[28]  S. Dimauro,et al.  Depletion of muscle mitochondrial DNA in AIDS patients with zidovudine-induced myopathy , 1991, The Lancet.

[29]  M. Dalakas,et al.  Mitochondrial myopathy caused by long-term zidovudine therapy. , 1990, The New England journal of medicine.

[30]  C. H. Chen,et al.  Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2',3'-dideoxycytidine. , 1989, The Journal of biological chemistry.

[31]  F. Sanger,et al.  Sequence and organization of the human mitochondrial genome , 1981, Nature.

[32]  T. S. Rao,et al.  Total synthesis of 2′-deoxy-2′-arafluoro-tubercidin, -toyocamycin, -sangivamycin and certain related nucleosides , 1995 .

[33]  R. Schinazi,et al.  Enantiomeric 2',3'-dideoxycytidine derivatives are potent human immunodeficiency virus inhibitors in cell cultures. , 1994, Comptes rendus de l'Academie des sciences. Serie III, Sciences de la vie.

[34]  D. Wallace,et al.  Diseases of the mitochondrial DNA. , 1992, Annual review of biochemistry.